Skip to main content
SpringerLink
Log in

Pemphigus vulgaris

  • Chapter
European Handbook of Dermatological Treatments

  • 365 Accesses

Abstract

Pemphigus (from the Greek pemphix = blister) vulgaris (from the Latin for common) (PV) is the most frequent form of a group of mucocutaneous diseases (autoimmune pemphigus) characterized by intraepithelial blister formation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  • Amagai M, Hashimoto T, Shimizu N et al. Absorption of pathogenic autoantibodies by the extra-cellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994; 94: 59–67.

    Article  PubMed  CAS  Google Scholar 

  • Bjarnason B, Skoglund C, Flosattodir E. Childhood pemphigus vulgaris treated with dapsone: a case report. Pediatr Dermatol 1998; 15: 381–3.

    Article  PubMed  CAS  Google Scholar 

  • Calebotta A, Saenz AM, Gonzales F et al. Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients. Int Dermatol 1999, 38: 217–21.

    Article  CAS  Google Scholar 

  • Ciompi ML, Marchetti G, Bazzichi L et al. Dpenicillamine and gold salt treatments were complicated by myasthenia and pemphigus, respectively, in the same patient with rheumatoid arthritis. Rheumatol Int 1995; 15: 95–7.

    Article  PubMed  CAS  Google Scholar 

  • Colonna L, Cianchini G, Frezzolini A et al. Intravenous immunoglobulins for pemphigus vulgaris: adjuvant or first choice therapy? Br J Dermatol 1998; 138: 1102–3.

    Article  PubMed  CAS  Google Scholar 

  • Dumas V, Roujeau JC, Wolkenstein P et al. The treatment of mild pemphigus vulgaris and pemphigus foliaceus with a topical corticosteroid. Br J Dermatol 1999; 140: 1127–9.

    Article  PubMed  CAS  Google Scholar 

  • Engineer L, Bhol KC, Ahmed AR. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris. JAm Acad Dermatol 2000; 43: 1049–57.

    Article  CAS  Google Scholar 

  • Enk A, Knop J. Adjuvante Therapie von Pemphigus vulgaris und Pemphigus foliaceus mit intravenösen Immunoglobulinen. Hautarzt 1998; 49: 774–6.

    Article  PubMed  CAS  Google Scholar 

  • Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999; 135: 54–6.

    Article  PubMed  CAS  Google Scholar 

  • Euler HH, Loeffler H, Christophers E. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol 1987; 123: 1205–10.

    Article  PubMed  CAS  Google Scholar 

  • Fleischli ME, Valek RH, Pandya AG. Pulse intravenous cyclophosphamide therapy in pemphigus. Arch Dermatol 1999; 135: 5 7–61.

    Google Scholar 

  • Fox LP, Pandya AG. Pulse intravenous cyclophosphamide therapy for dermatologic disorders. Dermatol Clin 2000; 18: 459–73.

    Article  PubMed  CAS  Google Scholar 

  • Gooptu C, Staughton RCD. Use of topical cyclosporin in oral pemphigus. J Am Acad Dermatol 1998; 38: 860–1.

    Article  PubMed  CAS  Google Scholar 

  • Grando SA, Dahl MV. Nicotine and pemphigus. Arch Dermatol 2000; 136: 1269.

    Article  PubMed  CAS  Google Scholar 

  • Grundmann-Kollmann M, Kaskel P, Leiter U et al. Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy. Arch Dermatol 1999; 135: 724–5.

    Article  PubMed  CAS  Google Scholar 

  • Harman KE, Black MM. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999; 140: 865–74.

    Article  PubMed  CAS  Google Scholar 

  • Hayag MV, Cohen JA, Kerdel FA. Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgaris. J Am Acad Dermatol 2000; 43: 1065–9.

    Article  PubMed  CAS  Google Scholar 

  • Ioannides D, Chrysomallis F, Bystryn JC. Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol 2000; 136: 868–72.

    Article  PubMed  CAS  Google Scholar 

  • Jackson AP, Hall AG, McLelland J. Thiopurine methyltransferase levels should be measured before commencing patients on azathioprine. Br J Dermatol 1997; 136: 133–4.

    Article  PubMed  CAS  Google Scholar 

  • Jolles S, Hughes J, Rustin M. Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris. J Am Acad Dermatol 1999; 40: 499–500.

    Article  PubMed  CAS  Google Scholar 

  • Mehta JN, Martin AG. A case of pemphigus vulgaris improved by cigarette smoking. Arch Dermatol 2000; 136: 15–17.

    Article  PubMed  CAS  Google Scholar 

  • Mignogna MD, Lo Muzio L, Mignogna RE et al. Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases. J Oral Pathol Med 2000; 29: 145–52.

    Article  PubMed  CAS  Google Scholar 

  • Ogata K, Yasuda K, Matsushita M, Kodama H. Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method. J Dermatol 1999; 26: 236–9.

    PubMed  CAS  Google Scholar 

  • Ozog DM, Gogstetter DS, Scott G, Gaspari AA. Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid. Arch Dermatol 2000; 136: 1133–8.

    Article  PubMed  CAS  Google Scholar 

  • Pacor ML, Biasi D, Carletto A et al. Ciclosporina topica nel trattamento del pemfigo orale. Minerva Stomatol 1998; 47: 183–6.

    PubMed  CAS  Google Scholar 

  • Pandya AG, Dyke C. Treatment of pemphigus with gold. Arch Dermatol 1998; 134: 1104–7.

    Article  PubMed  CAS  Google Scholar 

  • Pasricha JS, Khaitan BK, Raman S, Chandra M. Dexamethasone-cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 1995; 34: 875–82.

    Article  PubMed  CAS  Google Scholar 

  • Piontek JO, Borberg H, Sollberg S et al. Severe exacerbation of pemphigus vulgaris in pregnancy: successful treatment with plasma exchange. Br J Dermatol 2000; 143: 455–6.

    Article  PubMed  CAS  Google Scholar 

  • Proby CM, Ota T, Suzuki H et al. Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris. Br Dermatol 2000; 142: 321–30.

    Article  CAS  Google Scholar 

  • Roujeau JC. Pulse glucocorticoid therapy. The `big shot’ revisited. Arch Dermatol 1996; 132: 1499–502.

    Article  PubMed  CAS  Google Scholar 

  • Ruocco E, Aurilia A, Ruocco V. Precautions and suggestions for pemphigus patients. Dermatology 2001; 203: 201–7.

    Article  PubMed  CAS  Google Scholar 

  • Ruocco V, Astarita, Pisani M. Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus. Dermatologica 1984; 168: 219–23.

    Article  PubMed  CAS  Google Scholar 

  • Ruocco V, Brenner S, Ruocco E. Pemphigus and diet: does a link exist? Int J Dermatol 2001; 40: 161–3.

    Article  PubMed  CAS  Google Scholar 

  • Ruocco V, Rossi A, Argenziano G, et al. Pathogenicity of the intercellular antibodies of pemphigus and their periodic removal from the circulation by plasmapheresis. Br JDermatol 1978; 98: 237–41.

    Article  CAS  Google Scholar 

  • Ruocco V, Guerrera V, Lo Schiavo A, Pinto F. Il trattamento del pemfigo oggi. G It Dermatol Venereol 1997; 132: 259–69.

    Google Scholar 

  • Ruocco V, Ruocco E, Wolf R. Bullous diseases: unapproved treatments or indications. Clin Dermatol 2000; 18: 191–5.

    Article  PubMed  CAS  Google Scholar 

  • Sami N, Qureshi A, Ruocco E, Ahmed RA. Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris. Arch Dermatol 2002; 138: 1158–62.

    Article  PubMed  CAS  Google Scholar 

  • Sato N, Satake S, Fujiwara S et al. Pemphigus vulgaris treated with combined oral cyclosporin and cyclophosphamide. Clin Exp Dermatol 1998; 23: 92–6.

    Article  PubMed  CAS  Google Scholar 

  • Shah N, Green AR, Elgart GW, Kerdel F. The use of chlorambucil with prednisone in the treatment of pemphigus. J Am Acad Dermatol 2000; 42: 85–8.

    Article  PubMed  CAS  Google Scholar 

  • Sibaud V, Beylot-Barry M, Doutre MS, Beylot C. Pemphigus corticorésistant traité avec succès par immunoglobulines intraveineuses. Ann Dermatol Venereol 2000; 127: 408–10.

    PubMed  CAS  Google Scholar 

  • Smith TJ, Bystryn JC. Methotrexate as an adjuvant treatment for pemphigus vulgaris. Arch Dermatol 1999; 135: 1275–6.

    Article  PubMed  CAS  Google Scholar 

  • Stanley JR. Therapy of pemphigus vulgaris. Arch Dermatol 1999; 135: 76–7.

    Article  PubMed  CAS  Google Scholar 

  • Stanley JR. Understanding of the pathophysiology of pemphigus suggests innovative therapeutic approaches. Br J Dermatol 2000; 142: 208–9.

    Article  PubMed  CAS  Google Scholar 

  • Turner MS, Sutton D, Sauder DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2000; 43: 1058–64.

    Article  PubMed  CAS  Google Scholar 

  • Wollina U, Lange D, Looks A. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. Dermatology 1999; 198: 140–4.

    Article  PubMed  CAS  Google Scholar 

  • Yano C, Ishiji T, Kamide R, Niimura M. A case of pemphigus vulgaris successfully treated with single filtration plasmapheresis: a correlation of clinical disease activity with serum antibody levels. J Dermatol 2000; 27: 380–5.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. V. Ruocco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Ruocco
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. ‘A. Sygros’ Hospital, Department of Dermatology, University of Athens, 5, I. Dragoumi Street, 161 21, Athens, Greece

    Andreas D. Katsambas

  2. University Unit Allergology Professional and Environmental Dermatology, University of Florence, Via Alfani 37, 50 121, Florence, Italy

    Torello M. Lotti

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ruocco, V., Brenner, S., Ruocco, E. (2003). Pemphigus vulgaris. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07131-1_70

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-07131-1_70

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-05657-4

  • Online ISBN: 978-3-662-07131-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation